Sen. Collins, Colleagues Urge Patent Office to Address Anti-Competitive Drug Patent Thickets
June 17, 2022
June 17, 2022
WASHINGTON, June 17 -- Sen. Susan M. Collins, R-Maine, issued the following news release and letter:
U.S. Senator Susan Collins (R-ME) joined a bipartisan group of her colleagues in sending a letter requesting that the U.S. Patent and Trademark Office (PTO) address an issue that substantially contributes to soaring drug prices.
The Senators asked PTO Director Kathi Vidal to crack down on the practice of granting multiple patents for minor variations on a single inventio . . .
U.S. Senator Susan Collins (R-ME) joined a bipartisan group of her colleagues in sending a letter requesting that the U.S. Patent and Trademark Office (PTO) address an issue that substantially contributes to soaring drug prices.
The Senators asked PTO Director Kathi Vidal to crack down on the practice of granting multiple patents for minor variations on a single inventio . . .